Condensed Consolidated Statements of Operations and Comprehensive Earnings (Loss) (Unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013
Income Statement [Abstract]
Operating revenues (net of contractual allowances)	$ 25,108	$ 26,111	$ 49,717	$ 50,197
Less provision for bad debts of Healthcare Facilities Segment	1,982	2,231	4,215	4,288
Net revenues	23,126	23,880	45,502	45,909
Costs and Expenses
Cost of goods sold	5,456	6,485	10,072	10,760
Salaries, wages and benefits	10,589	10,722	21,406	21,514
Provision for bad debts of Specialty Pharmacy Segment	123	42	123	95
Supplies	2,034	2,054	4,140	3,982
Purchased services	1,025	1,350	2,202	2,595
Other operating expenses	1,968	3,030	4,340	5,973
Rent and lease expense	329	358	677	713
Insurance settlement	(1,000)	0	(1,000)	0
EHR incentive payments	0	(1,215)	0	(1,215)
Depreciation and amortization	580	763	1,215	1,537
Operating Profit (Loss)	2,022	291	2,327	(45)
Other Expense:
Interest expense-net	(234)	(238)	(464)	(480)
Earnings (Loss) from Continuing Operations before income taxes	1,788	53	1,863	(525)
Income Tax Expense (Benefit)	799	(297)	985	(95)
Earnings (Loss) from Continuing Operations	989	350	878	(430)
Loss from Discontinued Operations, net of tax	(12)	(123)	(314)	(501)
Net Earnings (Loss)	977	227	564	(931)
Other comprehensive income	0	0	0	0
Comprehensive Earnings (Loss)	$ 977	$ 227	$ 564	$ (931)
Continuing Operations:
Basic	$ 0.10	$ 0.04	$ 0.09	$ (0.05)
Diluted	$ 0.10	$ 0.04	$ 0.09	$ (0.05)
Discontinued Operations:
Basic	$ 0.00	$ (0.01)	$ (0.03)	$ (0.05)
Diluted	$ 0.00	$ (0.01)	$ (0.03)	$ (0.05)
Net Earnings (Loss):
Basic	$ 0.10	$ 0.02	$ 0.06	$ (0.10)
Diluted	$ 0.10	$ 0.02	$ 0.06	$ (0.10)
Weighted-Average Common Shares Outstanding:
Basic	9,443	9,443	9,443	9,443
Diluted	9,497	9,446	9,478	9,443